Skip to content

A observational study to assess the efficacy of Ayurvedic treatment in eyes affected by diabetes

A single centric, open labeled, observational study of selected ayurvedic therapies in the management of diabetic retinopathy, grade-1.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2012/12/003259
Enrollment
50
Registered
2012-12-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diabetic Retinopathy

Interventions

None listed

Sponsors

Dept of AYUSH Ministry of HealthGovt of IndiaNew Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex aged between 30 to 80 years. Patients presenting with signs and symptoms of Diabetic Retinopathy grade 1(US) with micro aneurysm and hemorrhage in one or two quadrants as seen in the Fundus Image. Willing and able to participate in the study for 12 months.

Exclusion criteria

Exclusion criteria: Severe cases of Diabetic Retinopathy with complications like internal haemorrhage, hard exudates, retinal detachment etc. Patients with concurrent serious Hepatic Dysfunction (defined as AST and/or ALT > 3 times of the upper normal limit) or Renal Dysfunction (defined as S. creatinine > 1.2mg/dl), uncontrolled Pulmonary Dysfunction (asthmatic and COPD patients) or other concurrent severe disease. Patient with poorly controlled Diabetes Mellitus (HbA1c > 10%) Women who are pregnant or lactating. Patient on steroids, oral contraceptive pills or estrogen replacement therapy. Smokers/Alcoholics and/or drug abusers. Patient with poorly controlled Hypertension ( >160/100 mm of Hg). Patients with evidence of malignancy. Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Psycho-Neuro- Endocrinal disorders, etc.). Any other condition which the P.I. thinks may jeopardize the study.

Design outcomes

Primary

MeasureTime frame
Fundus PhotographsTimepoint: Baseline,Second Inpatient visit, Third Inpatient visit and End of study visit

Secondary

MeasureTime frame
Fasting Blood Sugar,Post parandial Blood Sugar,LLiver Function Test, Renal Function TestTimepoint: Baseline and End of Study Visit

Countries

India

Contacts

Public ContactDr Darpan Gangil

Sreedhareeyam Ayurvedic Research and Development Institute

drsreekanthnp@sreedhareeyam.com91-485-2251578

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026